Western Mail AT THE heart of the empowering process is a belief that nursing staff are the healthcare workers closest to the patient. The ward sister, or charge attend upon is the individual through the [...]
Health
Western Mail PROSTATE disorders are much more indifferent than most people think, affecting more than 50% of men over the age of 50 and almost all men over the age of 80. A walnut-sized gland [...]
The deal between Ranbaxy and Daiichi Sankyo has encountered another obstacle which is forcing the promoter of Ranbaxy Company Mr. Malvinder Singh and family to pay a sum of Rs 1,000 crore to the government [...]
The Ranbaxy-Sankyo deal moves one step ahead to completion when the Board of Directors of Ranbaxy Laboratories finally gave a green signal by approving the allotment of equity shares and warrants to Daiichi on a [...]
For the first time, most important prostate cancer specialists say, they have a physic that can significantly cut men’s exposure to harm of developing the disease, dropping the incidence by 30 percent. But the discovery, [...]
The government has asked drug manufacturing companies to adopt a uniform code of conduct for marketing of medicines. An official from the department of pharmaceutical informed that such organizations are involved in pampering of doctors [...]
It seems that the tough times for Ranbaxy Laboratories are not going to stop soon. The drug major which has been facing serious charges from the US Food & Drug Administration for ‘misrepresentation of data’ [...]
The government holds plans of investing about Rs. 10,000crore in the area of drug research to help develop medicines and cures for treatment of diseases like Malaria and Tuberculosis. Large players from pharmaceutical industry are [...]
Ranbaxy Laboratories, the leading drug manufacturer of the country today reported a net loss of Rs 1004.8 crore for the year 2008 whereas it posted a net profit of Rs 617.7 crore in 2007. Despite [...]
Mid cap Drug firms from India are believed to report mixed profits for the quarter ended March due to high interest costs keeping the export gains from climbing more, which in turn is due to [...]
